FREQUENCY OF SARCOPENIA BY SARC-F SCREENING TEST AND RELATIONSHIP WITH QUALITY OF LIFE AND RISK FACTORS: PRELIMINARY REPORT OF A MULTICENTER STUDY


Borman P., Gül Ş., Eyigör S., Ceyhan Doğan S., Şahin N., Binay Safer V., ...More

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020), Barcelona, Spain, 20 - 23 August 2020, vol.31, pp.366-367

  • Publication Type: Conference Paper / Full Text
  • Volume: 31
  • Doi Number: 10.1007/s00198-020-05696-3
  • City: Barcelona
  • Country: Spain
  • Page Numbers: pp.366-367

Abstract

Objective: Sarcopenia is a common aging-induced generalized decrease

in musclemass, strength, and function. Owing to the impact of sarcopenia

on quality of life (QoL), disability and mortality, awareness is necessary

in order to correctly identify sarcopenic elderly and the related risk factors.

The aim of this study was to determine the frequency of sarcopenia

by SARC-F screening test and to estimate the association between

sarcopenia and QoL and risk factors.

Methods: A cross-sectional multicenter study with older adults

aged 60 years or older, was conducted in Physical Medicine and

Rehabilitation outpatient clinics of 7 health centers from October

2019 to January 2020. Demographic properties comprising age,

gender, BMI, comorbid diseases and drug usage were recorded.

Muscle strength, and physical performance were measured by

handgrip strength and 4m-gait speed tests respectively. Mini

Nutritional Assessment (MNA) was used for nutritional status

and sarcopenia quality of life questionnaire (SARQOL) was used

for QoL. SARC-F test with cut-off point of 4 was used for the

diagnosis of sarcopenia. The relationships with QoL, sarcopenia

and risk factors were evaluated.

Results: A total of 153 (106 female, 47 male) elderly with a

mean age of 71.8±5.9 y were included. According to SARC-F

criteria, the frequency of sarcopenia was determined as 37%. The

mean age, BMI, number of comorbid diseases and drugs were

significantly higher in sarcopenic group than in nonsarcopenic

elderly. The scores of SARQOL, MNA and gait speed were lower

indicating impaired QoL, malnutrition and functional disability in

sarcopenic elderly than in non-sarcopenic participants (p<0.001).

The most related risk factors with sarcopenia were recorded as

nutritional status, number of drugs, gait speed and BMI.

Conclusion: The frequency of sarcopenia screened by SARC-F

was higher than expected in our study group. Mostly QoL, malnutrition,

drugs for comorbidity, functional disability and obesity

were related with sarcopenia. These findings highlight the relevance

of the detection of sarcopenia and QoL in elderly as a part

of routine clinical practice in order to impede progression towards

disability and other adverse health outcomes.